CCL19 - Wikipedia
Chemokine (C-C motif) ligand 19 (CCL19) is a small cytokine belonging to the CC chemokine family that is also known as EBI1 ligand chemokine (ELC) and macrophage inflammatory …
CCL19: a novel prognostic chemokine modulates the tumor …
CCL19 modulates tumor immune microenvironment features and predicts prognosis in breast cancer patients. (A) We implemented with the CIBERSORT algorithms and identified …
CCL19 Gene - GeneCards | CCL19 Protein | CCL19 Antibody
2024年12月24日 · CCL19 (C-C Motif Chemokine Ligand 19) is a Protein Coding gene. Diseases associated with CCL19 include Allergic Contact Dermatitis and Polyradiculoneuropathy. …
CCL19 - an overview | ScienceDirect Topics
CCL19 is a chemokine ligand that binds to the CCR7 receptor, triggering a signaling cascade that leads to the migration of peripheral immune cells towards lymph nodes. AI generated definition …
CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions ...
Chemokine (C–C motif) ligand 19 (CCL19) is a critical regulator of the induction of T cell activation, immune tolerance, and inflammatory responses during continuous immune …
Does CCL19 act as a double-edged sword in cancer development?
2021年12月28日 · Through the induction of anti-tumor immune responses and inhibition of angiogenesis, CCL19 exerts tumor-suppressive functions. In contrast, CCL19 also acts as a …
Fibroblastic niches in action: CCL19+ reticular cells drive anti …
5 天之前 · Using single-cell transcriptomic analysis, Onder et al. identified two main clusters of CCL19-expressing CAFs in human non-small cell lung cancer (NSCLC), resembling the …
CCL19: a novel prognostic chemokine modulates the tumor …
2023年11月8日 · Background: CCL19 is a chemokine involved in cancer research due to its important role in the tumor microenvironment (TME) and clinical relevance in cancers. This …
CCL19-producing fibroblasts promote tertiary lymphoid structure ...
2024年8月12日 · We identify a fibroblast lineage secreting CCL19 that facilitates lymphocyte trafficking to TLSs. CCL19 treatment promotes TLS neogenesis and prevents tumor growth in …
CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 ...
2023年6月9日 · Wu et al. identified a CCL19+ functional state of dendritic cells associated with immunotherapy benefit, revealed these cells to facilitate immunotherapy-responsive …